The vitamin D endocrine reserve hypothesis: a secosteroid framework for upper airway vulnerability in obstructive sleep apnea

Obstructive sleep apnea and related sleep-disordered breathing phenotypes arise when structural load exceeds the compensatory capacity of the upper airway. This article proposes that reduced vitamin D endocrine reserve may be a modifiable biochemical determinant of such vulnerability in selected pediatric and adult phenotypes. Vitamin D is not treated as a simple nutrient but as a secosteroid endocrine system generated by cutaneous ultraviolet-B-dependent synthesis and exogenous dietary or supplemental intake, followed by transport, hepatic 25-hydroxylation, renal and extra-renal activation, receptor-mediated transcription and regulated catabolism. The central hypothesis is that vitamin D endocrine reserve becomes functionally insufficient when available signaling capacity is inadequate for the prevailing developmental, inflammatory, neuromuscular or mineral-remodeling demand. In that state, impaired calcium-phosphate homeostasis, altered parathyroid hormone and FGF23 feedback, reduced VDR-dependent myogenic competence, weakened epithelial immune regulation and chronic adenotonsillar inflammatory load may converge to lower upper airway resilience. The predicted phenotype is not vitamin-D-specific disease but reduced reserve of the craniofacial, lymphoid, tongue-suprahyoid and pharyngeal systems. The hypothesis predicts that vitamin D-axis biomarkers will associate more closely with selected structural and functional airway phenotypes than with apnea-hypopnea index alone, and that correction of a documented reserve deficit will be most informative when studied as an adjunct to anatomical, myofunctional or anti-inflammatory airway treatment. The model is falsifiable by prospective studies integrating vitamin D supply, endocrine activation, inflammatory markers, adenotonsillar assessment, orofacial function, airway imaging and polysomnography.